"Lipid cubic phase"@en . . "Article"@en . "In-house ultrafast macromolecular X-ray crystallography"@en . "Lyotropic liquid crystalline mesophases"@en . "Neurodegenerative diseases"@en . <0000-0002-0285-0637> . <189618086> . "Antioxidant-delivery nanosystems"@en . . "Image analysis"@en . "Angelina" . "Hydration"@en . "Drug delivery systems for oral administration"@en . "Lipid nanoparticles"@en . "In vivo Parkinson's disease transgenic mouse model"@en . "Biodegradable nanoparticles"@en . "Liquid crystalline carriers"@en . "Neuroprotective assemblies"@en . "Amyotrophic lateral sclerosis"@en . "Nanocarriers"@en . "Hybrid nonlamellar liquid crystalline nanostructures"@en . "Nanotherapeutic assemblies"@en . "Oxidative stress"@en . "Complex nanostructured fluid"@en . "Macromolecule"@en . "Cubosomic interfaces"@en . "Immunoglobulin"@en . "Nanomedicine"@en . "Angelina Angelova" . "Ginkgo biloba bioactive compounds"@en . "Alzheimer's disease"@en . "Lipid nanocarriers"@en . "Antioxidant"@en . "Blood-brain barrier"@en . "PH-responsive coating of lipid nanoparticles"@en . "N-arginine-modified chitosan"@en . "CPP-functionalized particles"@en . "5eeb4ff60ccc43db3bff471037dc5042" . "Diamond"@en . "Bioactive lipids"@en . "Kilohertz frame rate"@en . "Liquid crystalline nanocarriers"@en . "Nose-to-brain delivery"@en . "Eiger X 1M detector"@en . "Anti-inflammatory and anti-apoptotic agents"@en . "Electron microscopy"@en . "Lipids"@en . "Inverted hexagonal phase"@en . "Nanoparticle"@en . "Cryo-TEM"@en . "Neurodegeneration"@en . "Drug delivery nanomedicine"@en . "Hexosomes"@en . "PACAP"@en . . "Neurological long COVID-19"@en . "Lipid-based nanoparticles"@en . . . "Amphiphilic nanoparticles"@en . "Curcumin amphiphilic nanoparticles self-assembled nanoparticles solid lipid nanoparticles liposomes liquid crystalline carriers nanomedicine drug delivery neurodegenerative diseases Alzheimer's disease Parkinson's disease Huntington disease amyotrophic lateral sclerosis oxidative stress neuroprotection antioxidant blood-brain barrier SHSY-5Y cells"@en . "Nanoparticle therapeutic efficacy"@en . "Cervical carcinoma"@en . "Cell-penetrating peptides CPP"@en . "Liquid crystal"@en . "Liposomes"@en . "Parkinson's disease"@en . "Curcumin"@en . "Cubosomes"@en . "Freeze fracture"@en . "Lipid liquid crystalline nanoparticles"@en . "Antioxidant-delivery nanosystems lipid nanocarriers oxidative stress ROS neuroinflammation neurodegeneration neurological long COVID-19"@en . "PH-induced structural transformations"@en . "Mitochondria-mediated apoptosis"@en . "Nanostructured materials"@en . . "Brain-derived neurotrophic factor BDNF"@en . "Molecular Structure"@en . . . "Dynamic gastro-intestinal environment"@en . "Neuroprotection"@en . "Methemoglobin"@en . "In vivo and in vitro models"@en . "Nanofibers"@en . "Huntington disease"@en . "Liquid crystalline lipid nanoparticles"@en . "Neuroregeneration"@en . . "Lipid bilayer"@en . "Biotherapeutics"@en . "Lipid nanoparticles liquid crystalline nanocarriers cubosomes cell-penetrating peptide CPP CPP-functionalized particles pituitary adenylate cyclase-activating polypeptide PACAP neuroprotection nanomedicine"@en . "Neuroinvasive coronavirus infection"@en . "Cubic phase nanoparticles cubosomes"@en . "Lipid replacement therapy"@en . "Neurological long COVID"@en . "Docosapentaenoyl phospholipids"@en . "Mathematical model"@en . "Lipid"@en . "Aloe vera polysaccharides"@en . "PUFA-plasmalogens"@en . "Nanomedicine for growth factor delivery"@en . . "Hemoglobine"@en . "Cell-penetrating peptide CPP"@en . "Drug delivery system"@en . "Cubosome"@en . "Endoplasmic reticulum stress"@en . . . "Angelova" . . . "Fast Xray diffraction data acquisition"@en . "Nanotherapy"@en . "PUFAs"@en . "Drug delivery"@en . . "Neuroinflammation"@en . "Nanoparticles"@en .